Please Wait.....
Report
Global Embolization Particle Market to 2027
Market Report I 2023-05-10 I 113 Pages I Market Research Future
Global Embolization Particle Market to 2027
Market Overview
A non-invasive therapy known as embolisation, the Endovascular Particle is a cutting-edge concept that intends to halt not only hemorrhage but also ways to stop blood circulation to a tumour in a logical order to diminish it or in readiness for total abolition. Few embolised particles or tiny materials are forcefully injected into the clinic's patients' critical veins during the advanced process known as embolisation particle in order to entirely block or stop the blood flow to conventional cancerous cells. A very small percentage of individuals who have pre-existing tumours that current surgery cannot entirely remove have the option of embolisation. Tumors that are too large to be cured with current ablation techniques can be treated with embolisation particles. Ablation can also use embolisation particles. Embolization does, without a doubt, limit some of the blood flow to the healthy liver tissue that is present inside the body, thus it might not be a good alternative for some people whose livers have been damaged by diseases like serious hepatitis- or cirrhosis-related disorders. A significant part of contemporary interventional radiology uses embolisation particles in a variety of treatments.
Segment Overview
Insights into various market segments, including Structure, Application, and Region, can be found in the global embolisation particle market. The degree of occlusion, contemporary application, end-user, and numerous product kinds are used to segment the global market.
Research organisations, traders, importers, exporters, suppliers, and industry end users are the main market participants. The idea is picking up steam. The businesses are concentrating more on enhancing their methods for product innovation.
Many embolisation particle markets are being broken down and researched regionally, including those in Europe, Asia Pacific, North America, and the rest of the world.
Regional Analysis
Without a question, North America is the market leader because to the significant presence of international competitors in this area and the rapid improvement of technology. Geography predicts that North America will account for the largest share of profits owing to the increased use of various cloud-based services by means of manufacturing systems and various distribution channels. In addition, the market for the Asia Pacific region is expected to expand quickly due to increased investment.
Major Players
Market industry participants include: Medtronics, GuerbetTerumoBTG International Ltd. Sirtex, Boston Scientific Corporation, and Merit Medical.
COVID 19 Impacts
The market analysis for embolisation particles and 215 other nations have both been impacted by COVID 19. Countries have implemented lockdowns to address the harmful consequences, which has hurt the market for embolisation particles. The epidemic presents the industry with a number of difficulties because it has an international impact. Many elements, including supply chain risk, distribution issues, a lack of workforce workers, and drastically reduced development activities, have had a major impact on current demand and supply. Consumers are not as engaged as they once were. There are significant strategic developments going on. Due to the rising demand from customers all over the world, MNCs are spending more in the market for embolisation particles.
TABLE OF CONTENT
1 REPORT PROLOGUE
2 MARKET INTRODUCTION
2.1 DEFINITION 15
2.2 SCOPE OF THE STUDY 15
2.2.1 RESEARCH OBJECTIVE 15
2.2.2 ASSUMPTIONS 15
2.2.3 LIMITATIONS 16
3 RESEARCH METHODOLOGY
3.1 PRIMARY RESEARCH METHODOLOGY 18
3.2 SECONDARY RESEARCH METHODOLOGY 19
3.3 MARKET SIZE ESTIMATION 20
3.4 MARKET SHARE ANALYSIS 22
3.5 TRADE ANALYSIS 22
3.6 MARKET PRICING APPROACH 22
4 MARKET DYNAMICS
4.1 INTRODUCTION 23
4.2 DRIVER 24
4.2.1 GROWING DEMAND OF EMBOLIZATION PARTICLES FOR INTERVENTIONAL RADIOLOGY AND INTERVENTIONAL CARDIOVASCULAR PROCEDURE (IMPACT WEIGHTAGE- 35%) 24
4.2.2 EMBOLIZATION IS BEST MINIMALLY INVASIVE ALTERNATIVES AVAILABLE FOR THE
INTERVENTIONAL PROCEDURES (IMPACT WEIGHTAGE- 30%) 25
4.2.3 INCREASING PREVALENCE OF VARIOUS TYPES OF CANCER IS ONE OF THE MAJOR FACTOR RESPONSIBLE FOR MARKET GROWTH (IMPACT WEIGHTAGE- 25%) 26
4.2.4 FAVOURABLE REIMBURSEMENT SCENARIO (IMPACT WEIGHTAGE- 10%) 27
4.3 RESTRAINTS 28
4.3.1 LESS NUMBER OF INTERVENTIONAL NEURORADIOLOGISTS AND INTERVENTIONAL
NEURORADIOLOGY (INR) LABS (IMPACT WEIGHTAGE- 40%) 28
4.3.2 STRICT REGULATORY RULES (IMPACT WEIGHTAGE-60% 29
4.4 OPPORTUNITIES 30
4.4.1 RECENT ADVANCES IN MICROSPHERE TECHNOLOGIES 30
4.5 MEGA TRENDS 30
4.6 MACROECONOMIC INDICATORS 31
5 MARKET FACTOR ANALYSIS
5.1 PORTER'S 5 FORCES ANALYSIS 32
5.1.1 BARGAINING POWER OF SUPPLIERS 33
5.1.2 BARGAINING POWER OF BUYERS 33
5.1.3 THREAT OF NEW ENTRANTS 33
5.1.4 THREAT OF SUBSTITUTES 33
5.1.5 INTENSITY OF RIVALRY 33
5.2 VALUE CHAIN ANALYSIS 34
5.2.1 R&D 34
5.2.2 CLINICAL TEST & LEGAL ISSUES 35
5.2.3 MANUFACTURING 35
5.2.4 MARKETING & SALES 35
5.3 PURCHASING ACTIVITIES, STRATEGIES AND IMPLICATIONS 36
5.4 INVESTMENT OPPORTUNITY ANALYSIS 36
5.5 PRICING IMPACT OF EMBOLIZATION PARTICLE (LIPIODOL): EFFECTS & IMPLICATIONS 37
5.6 REIMBURSEMENT ISSUES IN EMBOLIZATION PROCEDURES 38
6 GLOBAL EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE
6.1 INTRODUCTION 40
6.2 RADIOEMBOLIZATION SPHERES 41
6.3 DRUG ELUTING BEADS 42
7 GLOBAL EMBOLIZATION PARTICLE MARKET, BY APPLICATION
7.1 INTRODUCTION 43
7.2 ONCOLOGY 45
7.3 UROLOGY 46
7.4 PERIPHERAL VASCULAR DISEASE 47
7.5 NEUROLOGY 48
8 GLOBAL EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION
8.1 INTRODUCTION 49
8.1.1 PROXIMAL 50
8.1.2 DISTAL 50
9 GLOBAL EMBOLIZATION PARTICLE MARKET, BY END USER
9.1 INTRODUCTION 51
9.2 HOSPITALS & CLINICS 52
9.3 AMBULATORY CENTERS 53
10 GLOBAL EMBOLIZATION PARTICLE MARKET, BY REGION
10.1 INTRODUCTION 54
10.2 AMERICAS 56
10.2.1 U.S. 59
10.2.2 CANADA 61
10.2.3 SOUTH AMERICA 63
10.3 EUROPE 66
10.3.1 GERMANY 69
10.3.2 FRANCE 71
10.3.3 UK 73
10.3.4 ITALY 75
10.3.5 SPAIN 77
10.3.6 REST OF EUROPE 79
10.4 ASIA PACIFIC 82
10.4.1 JAPAN 85
10.4.2 CHINA 87
10.4.3 INDIA 89
10.4.4 REPUBLIC OF KOREA 91
10.4.5 AUSTRALIA 93
10.4.6 REST OF ASIA PACIFIC 95
10.4.7 MIDDLE EAST & AFRICA 97
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION 100
11.2 COMPANY SHARE ANALYSIS 101
12 COMPANY PROFILES
12.1 BOSTON SCIENTIFIC CORPORATION 102
12.1.1 COMPANY OVERVIEW 102
12.1.2 FINANCIALS 102
12.1.3 PRODUCTS 102
12.1.4 STRATEGY 102
12.1.5 KEY DEVELOPMENTS 102
12.2 GUERBET 103
12.2.1 COMPANY OVERVIEW 103
12.2.2 FINANCIALS 103
12.2.3 PRODUCTS 103
12.2.4 STRATEGY 103
12.2.5 KEY DEVELOPMENTS 103
12.3 BTG INTERNATIONAL LTD 104
12.3.1 COMPANY OVERVIEW 104
12.3.2 FINANCIALS 104
12.3.3 PRODUCTS 104
12.3.4 STRATEGY 104
12.3.5 KEY DEVELOPMENTS 104
12.4 MEDTRONICS 105
12.4.1 COMPANY OVERVIEW 105
12.4.2 FINANCIALS 105
12.4.3 PRODUCTS 105
12.4.4 STRATEGY 105
12.4.5 KEY DEVELOPMENTS 105
12.5 SIRTEX 106
12.5.1 COMPANY OVERVIEW 106
12.5.2 FINANCIALS 106
12.5.3 PRODUCTS 106
12.5.4 STRATEGY 106
12.5.5 KEY DEVELOPMENTS 106
12.6 TERUMO 107
12.6.1 COMPANY OVERVIEW 107
12.6.2 FINANCIALS 107
12.6.3 PRODUCTS 107
12.6.4 STRATEGY 107
12.6.5 KEY DEVELOPMENTS 107
12.7 MERIT MEDICAL 108
12.7.1 COMPANY OVERVIEW 108
12.7.2 FINANCIALS 108
12.7.3 PRODUCTS 108
12.7.4 STRATEGY 108
12.7.5 KEY DEVELOPMENTS 108
13 MRFR CONCLUSION
13.1 KEY FINDINGS 109
13.1.1 FROM CEO'S VIEW POINT 109
13.1.2 UNMET NEEDS 109
13.2 KEY COMPANIES TO WATCH 109
14 APPENDIX
14.1 DISCUSSION BLUE PRINT 110
14.2 REFERENCES 112
LIST OF TABLES
TABLE 1 PRIMARY INTERVIEWS 18
TABLE 2 SAMPLE SIZE DETERMINATION OF END-USERS (HOSPITALS, CLINICS) 19
TABLE 3 AVERAGE PRICING OF LIPIODOL IN VARIOUS COUNTRIES (USD) 38
TABLE 4 GLOBAL EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 40
TABLE 5 GLOBAL EMBOLIZATION PARTICLE MARKET FOR RADIOEMBOLIZATION SPHERES, BY REGION,
2020-2027 (USD MILLION) 41
TABLE 6 GLOBAL EMBOLIZATION PARTICLE MARKET FOR DRUG ELUTING BEADS, BY REGION,
2020-2027 (USD MILLION) 42
TABLE 7 GLOBAL EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 43
TABLE 8 GLOBAL EMBOLIZATION PARTICLE MARKET FOR ONCOLOGY, BY REGION, 2020-2027 (USD MILLION) 45
TABLE 9 GLOBAL EMBOLIZATION PARTICLE MARKET FOR UROLOGY, BY REGION, 2020-2027 (USD MILLION) 46
TABLE 10 GLOBAL EMBOLIZATION PARTICLE MARKET FOR PERIPHERAL VASCULAR DISEASE, BY REGION,
2020-2027 (USD MILLION) 47
TABLE 11 GLOBAL EMBOLIZATION PARTICLE MARKET FOR NEUROLOGY, BY REGION, 2020-2027 (USD MILLION) 48
TABLE 12 GLOBAL EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 49
TABLE 13 GLOBAL EMBOLIZATION PARTICLE MARKET FOR PROXIMAL, BY REGION, 2020-2027 (USD MILLION) 50
TABLE 14 GLOBAL EMBOLIZATION PARTICLE MARKET FOR DISTAL, BY REGION, 2020-2027 (USD MILLION) 50
TABLE 15 GLOBAL EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 51
TABLE 16 GLOBAL EMBOLIZATION PARTICLE MARKET FOR HOSPITALS & CLINICS, BY REGION,
2020-2027 (USD MILLION) 52
TABLE 17 GLOBAL EMBOLIZATION PARTICLE MARKET FOR AMBULATORY CENTERS, BY REGION,
2020-2027 (USD MILLION) 53
TABLE 18 GLOBAL EMBOLIZATION PARTICLE MARKET, BY REGION, 2020-2027 (USD MILLION) 54
TABLE 19 AMERICAS EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020 & 2027 (USD MILLION) 56
TABLE 20 AMERICA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 57
TABLE 21 AMERICA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 58
TABLE 22 AMERICA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 58
TABLE 23 AMERICA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 59
TABLE 24 U.S. EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 59
TABLE 25 U.S. EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 60
TABLE 26 U.S. EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 60
TABLE 27 U.S. EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 61
TABLE 28 CANADA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 61
TABLE 29 CANADA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 62
TABLE 30 CANADA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 62
TABLE 31 CANADA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 63
TABLE 32 SOUTH AMERICA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 63
TABLE 33 SOUTH AMERICA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 64
TABLE 34 SOUTH AMERICA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION,
2020-2027 (USD MILLION) 64
TABLE 35 SOUTH AMERICA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 65
TABLE 36 EUROPE EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 66
TABLE 37 EUROPE EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 67
TABLE 38 EUROPE EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 68
TABLE 39 EUROPE EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 68
TABLE 40 EUROPE EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 69
TABLE 41 GERMANY EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 69
TABLE 42 GERMANY EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 70
TABLE 43 GERMANY EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 70
TABLE 44 GERMANY EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 71
TABLE 45 FRANCE EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 71
TABLE 46 FRANCE EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 72
TABLE 47 FRANCE EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 72
TABLE 48 FRANCE EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 73
TABLE 49 UK EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 73
TABLE 50 UK EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 74
TABLE 51 UK EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 74
TABLE 52 UK EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 75
TABLE 53 ITALY EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 75
TABLE 54 ITALY EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 76
TABLE 55 ITALY EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 76
TABLE 56 ITALY EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 77
TABLE 57 SPAIN EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 77
TABLE 58 SPAIN EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 78
TABLE 59 SPAIN EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 78
TABLE 60 SPAIN EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 79
TABLE 61 REST OF EUROPE EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 79
TABLE 62 REST OF EUROPE EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 80
TABLE 63 REST OF EUROPE EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION,
2020-2027 (USD MILLION) 80
TABLE 64 REST OF EUROPE EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 81
TABLE 65 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020-2027 (USD MILLION) 82
TABLE 66 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 83
TABLE 67 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 84
TABLE 68 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 84
TABLE 69 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 85
TABLE 70 JAPAN EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 85
TABLE 71 JAPAN EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 86
TABLE 72 JAPAN EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 86
TABLE 73 JAPAN EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 87
TABLE 74 CHINA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 87
TABLE 75 CHINA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 88
TABLE 76 CHINA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 88
TABLE 77 CHINA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 89
TABLE 78 INDIA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 89
TABLE 79 INDIA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 90
TABLE 80 INDIA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 90
TABLE 81 INDIA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 91
TABLE 82 REPUBLIC OF KOREA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 91
TABLE 83 REPUBLIC OF KOREA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 92
TABLE 84 REPUBLIC OF KOREA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION,
2020-2027 (USD MILLION) 92
TABLE 85 REPUBLIC OF KOREA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 93
TABLE 86 AUSTRALIA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 93
TABLE 87 AUSTRALIA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 94
TABLE 88 AUSTRALIA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020-2027 (USD MILLION) 94
TABLE 89 AUSTRALIA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 95
TABLE 90 REST OF ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION) 95
TABLE 91 REST OF ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 96
TABLE 92 REST OF ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION,
2020-2027 (USD MILLION) 96
TABLE 93 REST OF ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 97
TABLE 94 MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE,
2020-2027 (USD MILLION) 97
TABLE 95 MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020-2027 (USD MILLION) 98
TABLE 96 MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION,
2020-2027 (USD MILLION) 98
TABLE 97 MIDDLE EAST & AFRICA EMBOLIZATION PARTICLE MARKET, BY END USER, 2020-2027 (USD MILLION) 99
LIST OF FIGURES
FIGURE 1 GLOBAL EMBOLIZATION PARTICLE MARKET SHARE, BY PRODUCT TYPE, 2020 (%) 12
FIGURE 2 GLOBAL EMBOLIZATION PARTICLE MARKET SHARE, BY APPLICATIONS, 2020 (%) 13
FIGURE 3 GLOBAL EMBOLIZATION PARTICLE MARKET, BY REGION, 2020 (%) 14
FIGURE 4 MARKET STRUCTURE 16
FIGURE 5 RESEARCH METHODOLOGY 17
FIGURE 6 FORECAST MODEL 21
FIGURE 7 PORTERS FIVE FORCES MODEL 32
FIGURE 8 VALUE CHAIN: TISSUE MICROARRAY 34
FIGURE 9 GLOBAL EMBOLIZATION PARTICLE MARKET, BY PRODUCT TYPE, 2020 & 2027 (USD MILLION) 41
FIGURE 10 GLOBAL EMBOLIZATION PARTICLE MARKET, BY APPLICATION, 2020 & 2027 (USD MILLION) 44
FIGURE 11 GLOBAL EMBOLIZATION PARTICLE MARKET, BY LEVEL OF OCCLUSION, 2020 & 2027 (USD MILLION) 49
FIGURE 12 GLOBAL EMBOLIZATION PARTICLE MARKET, BY END USER, 2020 & 2027 (USD MILLION) 51
FIGURE 13 GLOBAL EMBOLIZATION PARTICLE MARKET, BY REGION, 2020 & 2027 (USD MILLION) 55
FIGURE 14 AMERICA EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020 (%) 57
FIGURE 15 EUROPE EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020 (%) 67
FIGURE 16 ASIA PACIFIC EMBOLIZATION PARTICLE MARKET, BY COUNTRY, 2020 (%) 83
FIGURE 17 GLOBAL EMBOLIZATION PARTICLE MARKET: COMPETITIVE LANDSCAPE 100
FIGURE 18 GLOBAL EMBOLIZATION PARTICLE MARKET: COMPANY SHARE ANALYSIS, 2020 (%) 101
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security